Amalia Lafuente Flo

Title: Amalia Lafuente Flo: Innovator in Predictive Medicine

Introduction

Amalia Lafuente Flo is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of predictive medicine, particularly in understanding the onset of extrapyramidal symptoms (EPS) induced by antipsychotic treatments. With a total of 2 patents, her work is paving the way for personalized medicine approaches.

Latest Patents

Amalia's latest patents focus on methods for predicting the onset of EPS associated with antipsychotic-based treatments. These inventions not only provide predictive insights but also offer personalized medicine solutions based on the genetic sequences of several SNPs linked to EPS. Additionally, her patents include kits designed for implementing these diagnostic and predictive methods, enhancing the potential for tailored patient care.

Career Highlights

Throughout her career, Amalia has worked with esteemed institutions such as the Universitat De Barcelona and Hospital Clinic De Barcelona. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Amalia has collaborated with notable colleagues, including Sergi Mas Herrero and Patricia Gassó Astorga. These partnerships have enriched her research and expanded the impact of her innovations in predictive medicine.

Conclusion

Amalia Lafuente Flo is a trailblazer in the realm of predictive medicine, with her innovative patents addressing critical health challenges. Her work exemplifies the intersection of genetics and personalized healthcare, promising advancements in patient treatment strategies.